Drug class
Hypoglycemic Agents clinical trials
A class of medicines: the studies that test any of its 52 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.
Keep track of what changes. Save the hypoglycemic agents studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesMedicines in this class
Studies that test each. A study of two counts under both, and once above.
- Insulin aspart, insulin aspart protamine drug combination 30:70
- 37
And 12 more, each tested in fewer studies.
Studies by the year they started
3,877 studies that test it; most in 2008 (214); 4 more planned to start later
| Year | Studies |
|---|---|
| 1992 | 2 |
| 1993 | 2 |
| 1994 | 4 |
| 1995 | 3 |
| 1996 | 3 |
| 1997 | 7 |
| 1998 | 4 |
| 1999 | 11 |
| 2000 | 28 |
| 2001 | 60 |
| 2002 | 91 |
| 2003 | 122 |
| 2004 | 144 |
| 2005 | 161 |
| 2006 | 182 |
| 2007 | 175 |
| 2008 | 214 |
| 2009 | 178 |
| 2010 | 194 |
| 2011 | 195 |
| 2012 | 179 |
| 2013 | 184 |
| 2014 | 186 |
| 2015 | 173 |
| 2016 | 194 |
| 2017 | 136 |
| 2018 | 139 |
| 2019 | 140 |
| 2020 | 104 |
| 2021 | 113 |
| 2022 | 124 |
| 2023 | 110 |
| 2024 | 115 |
| 2025 | 109 |
| 2026 | 91 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
- Obesity
- 43
Who runs them
Industry 1,706 · Other 2,221
Novo Nordisk A/S (297) · Sanofi (165) · Boehringer Ingelheim (108) · Eli Lilly and Company (104) · Merck Sharp & Dohme LLC (91) · Takeda (76) · AstraZeneca (72) · GlaxoSmithKline (58)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.
Testing one of them · 3,927
- Canagliflozin Plus Progestin for Atypical Endometrial Hyperplasia and Early-Stage Endometrial CancerNot yet recruitingPhase 2Wang YingmeiNCT07890064Written as Metformin
- Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid CancerRecruitingPhase 3Medical University of BialystokNCT05468554Written as metformin
- Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)RecruitingPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT03109288Written as Pioglitazone
- Topical Insulin for GlaucomaRecruitingPhase 1Stanford UniversityNCT05206877Written as Insulin, 4 units
- Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) EpendymomaRecruitingPhase 2University of California, San FranciscoNCT07226453Written as Metformin
- Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric SurgeryRecruitingPhase 4University of California, IrvineNCT05975580Written as Topiramate
- Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing ChemotherapyRecruitingPhase 3City of Hope Medical CenterNCT06763328Written as Extended Release Metformin Hydrochloride
- Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison StudyRecruitingPhase 4Mayo ClinicNCT06972056Written as Topiramate 100 mg
- Metformin IN Asthma for Overweight and Obese Individuals (MINA)RecruitingPhase 2Johns Hopkins UniversityNCT06273072Written as Metformin hydrochloride extended-release tablets
- Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3RecruitingNot applicableWashington University School of MedicineNCT07589387Written as Metformin
- Inositol and Metformin Administration in Mediterranean Diet and Low-Carbohydrate Diets in Women With PCOSRecruitingNot applicableDicle UniversityNCT07770711Written as Metformin
- Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and F2-F3 FibrosisRecruitingPhase 4Madrigal Pharmaceuticals, Inc.NCT07848191Written as ACTOS/pioglitazone
- Interplay of Central and Peripheral Vascular Effects of Insulin in ObesityNot yet recruitingEarly Phase 1University of Missouri-ColumbiaNCT07653464Written as human insulin
- Peripheral Vascular Effects of Insulin in ObesityNot yet recruitingEarly Phase 1University of Missouri-ColumbiaNCT07874945Written as human insulin
- A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy AdultsNot yet recruitingPhase 1InventisBio Co., LtdNCT07875842Written as Metformin
- A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation TherapyRecruitingPhase 1University of ArkansasNCT06044025Written as Metformin
- Preventing Injured Knees From osteoArthritis: Severity OutcomesRecruitingPhase 2Brigham and Women's HospitalNCT06096259Written as Metformin
- Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DICRecruitingPhase 4Tanta UniversityNCT07436663Written as Sitagliptin (DPP4 inhibitor)
- Osteogenic Potential of Topical Metformin Gel on Cystic Jaw DefectsNot yet recruitingNot applicableFayoum UniversityNCT07867236Written as For the Experimental Arm: 1% Metformin Gel
- DDI Study of ECC0509 With Metformin, Midazolam, and CaffeineNot yet recruitingPhase 1EccogeneNCT07873229Written as Metformin
See all 3,927 studies that test one of the hypoglycemic agents →
Codes
What other systems call Hypoglycemic Agents · ClinicalTrials.gg INT007643
- MeSH (NLM) D007004Hypoglycemic AgentsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007004 | Hypoglycemic Agents | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.